SIRIO Europe launches full FizzyBits portfolio for on-the-go supplementation
SIRIO Europe has launched a full range of FizzyBits, a line of instant fizzy tabs that dissolve on the tongue without water, according to the company. The platform, first introduced in 2025, now includes 10 formulations targeting areas like metabolic support, energy, and cognitive function. The expansion aims to address growing consumer demand for convenient supplement formats, with 22% of users taking more supplements due to improved formats, per the Innova Trends Survey 2026.
What is FizzyBits and Why Does It Matter?
FizzyBits are single-tablet supplements that dissolve on the tongue, eliminating the need for water. SIRIO Europe positioned the product as a solution to “pill fatigue,” a trend where consumers abandon supplements due to inconvenient formats. The company cited a 2026 survey showing 22% of consumers take more supplements when better formats exist, highlighting the commercial importance of product design in adherence.
Key Products and Clinical Backing
The premium offering, Aeion BodyBalance, includes BPL1, a postbiotic studied in a trial where 3 months of use reduced visceral fat and insulin resistance in abdominally obese individuals. Other formulations include FizzyBits Pulse, which combines iron and vitamin C to combat fatigue, and FizzyBits Spark, a caffeine-free cognitive support supplement with L-theanine and zinc. Each product targets specific health needs while emphasizing ease of use.
Industry Impact and Future Outlook
According to Alexej Dens, SIRIO Europe’s Sales Director, the FizzyBits range provides brands with ready-to-launch solutions across major health categories. “The formats are developed, regulatory groundwork is done, and sensory profiles are proven,” he said. Analysts suggest the water-free design could influence supplement trends, though long-term market success depends on consumer adoption and regulatory compliance.
Frequently Asked Questions
What is FizzyBits? FizzyBits are instant fizzy tabs that dissolve on the tongue, offering targeted nutrition without water. The platform includes 10 formulations for categories like metabolic support and cognitive function.
What clinical evidence supports FizzyBits? A trial on BPL1, a postbiotic in Aeion BodyBalance, showed reduced visceral fat and insulin resistance in abdominally obese individuals over 3 months.
How does FizzyBits differ from traditional supplements? The product eliminates the need for water, addresses “pill fatigue,” and includes flavors to mask unpleasant tastes, such as the lemon flavor in FizzyBits Pulse to counter iron’s metallic aftertaste.
What challenges might brands face in adopting FizzyBits? How could consumer preferences shape the future of supplement formats?